Skip to main content
. 2020 Jun 6;135:242–250. doi: 10.1016/j.ejca.2020.06.001

Table 6.

Multivariable logistic predictive model for respiratory distress and mortality outcomes.

n (%) ARDS
Mortality
OR CI 95% p value OR CI 95% p value
Age, >65 years 1.17 0.42–3.2 0.76 1.59 0.5–4.99 0.42
Sex, Female = 1 0.98 0.35–2.74 0.98 0.88 0.28–2.73 0.83
Smoking habit
 Former smoker 0.81 0.27–2.45 0.72 0.89 0.25–3.11 0.86
 Current smoker 2.4 0.48–11.8 0.28 2.48 0.5–12.54 0.27
Comorbidities
 Hypertensiona 1.5 0.5–4.43 0.46 2 0.68–5.88 0.21
 Diabetesa 2.4 0.63–9.44 0.19 1.15 0.34–3.9 0.81
 CKDa 3.5 0.46–26.18 0.22 2.39 0.29–19.85 0.42
 COPDa 0.79 0.18–3.34 0.75 0.35 0.05–2.23 0.26
 Previous VTEDa 1.79 0.48–6.7 0.39 4.82 1.14–20.3 0.03
 Chronic anaemiac 2.76 0.62–12.3 0.18 1.32
 ACEI/ARBsIb 0.64 0.11–3.5 0.6 0.23 0.02–2.23 0.2
 COPDd 1.69 0.33–8.62 0.52 1.43 0.25–8.33 0.68
Radiol infiltrates bilateral=1 21.4 4.2–108.55 <0.001 32.83 3.51–307 0.002
Neutropeniae
 <1500 0.46 0.13–1.58 0.21 0.62 0.16–2.37 0.43
 <500 10.36 0.93–114.52 0.056 16.54 1.43–190.9 0.025
Primary tumourf
 Overall lung cancer 1.81 0.49–6.7 0.37 2.35 0.58–9.51 0.22
 Colorectal cancer (lung=1) 1.65 0.1–16.97 0.81 2.33 0.17–30.94 0.52
 Breast cancer (lung=1) 0.9 0.12–6.54 0.9 2.47 0.17–34.23 0.5
 Genitourinary cancer (lung=1) 1.56 0.17–14.13 0.69 2.29 0.17–30.73 0.53
 Other tumours (lung=1) 1.86 0.37–9.19 0.44 2.13 0.42–10.82 0.36
Metastatic diseaseg 1.11 0.23–5.38 0.88 1.88 0.19–18.19 0.58
Visceral metastatasish 0.7 0.21–2.25 0.54 1.32 0.38–4.55 0.44
Pulmonary involvementi 1.96 0.63–6.14 0.24 4.34 1.26–14.95 0.02
Cancer Treamentj
 Chemotherapy alone 1.36 0.4-4-56 0.68 1.6 0.4–6.33 0.5
 Immunotherapy + Chemo 0.97 0.14–6.45 0.95 1,96 0.29–13.18 0.49
 Immnunotherapy alone 0.26 0.03–1.88 0.18 0.15 0.01–1.65 0.12

CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; VTED, venous thromboembolic disease; ACEi/ARBs, angiotensin converting enzyme inhibitor/angiotensin receptor blockers; ECOG, Eastern Cooperative Oncology Group; OR, odds ratio; CI, confidence interval.

a

Adjusted by age, sex, hypertension, diabetes, CKD, COPD, previous VTE, smoking habit.

b

Adjusted by age, sex, hypertension, diabetes, CKD, COPD, smoking habit.

c

Adjusted by age, sex, hypertension, diabetes, CKD, COPD, Previous VTE, smoking habit, oesophagogastric tumour.

d

Adjusted by age, sex, cardiopathy, previous VTED.

e

Adjusted by age, sex, hypertension, diabetes, CKD, COPD, Previous VTE, smoking habit.

f

Adjusted by age, sex, CT.

g

Adjusted by age, sex, COPD, previous VTE, metastasis, ECOG.

h

Adjusted by age, sex, previous VTE, pulmonary involvement.

i

Adjusted by age, sex, ECOG, metastasis, previous VTE.

j

Adjusted by age, sex, ECOG, metastasis, previous VTE, COPD.